SCHEMBL19424970

SCHEMBL19424970

CC1(C)CCC(CNCCNc2ccc(C(=O)NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)c(Oc3cccc4[nH]ccc34)c2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19425018 0.88 — —
SCHEMBL19424941 0.87 — —
SCHEMBL19424999 0.86 BCL2 (0.54) —
SCHEMBL19424985 0.85 — —
SCHEMBL19424741 0.85 BCL2 (0.60) —
SCHEMBL19424867 0.85 BCL2 (0.59) —
SCHEMBL19425085 0.85 BCL2 (0.63) —
SCHEMBL19424917 0.85 BCL2 (0.63) —
SCHEMBL19424880 0.84 BCL2 (0.58) —
SCHEMBL19425161 0.84 BCL2 (0.64) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10195213-B2 Chemical entities that kill senescent cells for use in treating age-related disease UNITY BIOTECHNOLOGY, INC. (US) 2019-02-05 — — US disclosed
US-20170281649-A1 COMPOUNDS AND THERAPEUTIC USES UNITY BIOTECHNOLOGY, INC. 2017-10-05 — — US disclosed
Send feedback